Qiagen Profit In Line - Quick Facts

(RTTNews) - Qiagen NV (QGEN), the Netherlands-based provider of sample and assay technologies, Wednesday reported third-quarter net earnings of $34.7 million or $0.14 per share compared with $40.7 million or $0.17 per share last year.

Excluding items, adjusted earnings for the quarter were $0.27 per share compared with $0.26 per share a year ago.

Revenues for the quarter were $336.5 million compared with $322 million in the prior year. Adjusted revenues were $336.8 million compared with $323.8 million a year ago.

Analysts polled by Thomson Reuters estimated earnings of $0.27 per share on revenues of $337.2 million for the quarter. Analysts' estimates typically exclude special items.

Looking ahead to the fourth quarter, the company expects adjusted earnings of $0.33 per share and sales growth of 4%, at constant exchange rate (CER). Analysts expect earnings of $0.34 per share on sales growth of 3.1%.

For the full year, the company now expects adjusted earnings per share of about $1.08 CER and sales growth of about 4% CER. It earlier estimated earnings of per share of $1.07 to 1.09 CER and sales growth of 4% to 5% CER.

Analysts expect earnings of $1.08 per share on revenue growth of 4.2% for the year.